KAVI-Institute of Clinical Research at the University of Nairobi is contributing research expertise to Kenya’s Ebola response, with Senior Scientist Prof. Omu Anzala co-leading the research pillar of the national Ebola task force. The pillar brings together multidisciplinary expertise to identify research priorities and generate evidence to inform the national response.

Every October, the world turns pink. Pink ribbons, pink buildings and pink profile pictures mark Breast Cancer Awareness Month, a time to remember those we have lost, celebrate those living with and beyond breast cancer, and, most importantly, help more people find it early.

September is a month that carries a double meaning. Around the world, it marks both Ovarian Cancer Awareness Month and Prostate Cancer Awareness Month, two very different cancers that share one important thing in common: they are often found late, simply because their early signs are quiet or easy to overlook.

Cancer, genes and family history

Throughout our September awareness campaign, we’ve returned to one simple idea: some cancers can run in families. If you’ve ever wondered what that really means, and why we keep encouraging people to know their family health history, this article is for you.

[Nairobi] — KAVI-Institute of Clinical Research (KAVI-ICR), part of the Faculty of Health Sciences at the University of Nairobi, welcomed Professor Jon Frampton, Professor of Stem Cell Biology and Head of Global Partnerships in the College of Medicine & Health at the University of Birmingham for a wide-ranging research visit. He was accompanied by Dr.

[Nairobi] — KAVI-Institute of Clinical Research (KAVI-ICR), part of the Faculty of Health Sciences at the University of Nairobi, welcomed Professor Jon Frampton, Professor of Stem Cell Biology and Head of Global Partnerships in the College of Medicine & Health at the University of Birmingham for a wide-ranging research visit. He was accompanied by Dr.

Rio de Janeiro, Brazil — KAVI–Institute of Clinical Research (KAVI-ICR), University of Nairobi, strengthened its global engagement in HIV vaccine research through active participation at AIDS 2026, the 26th International AIDS Conference, held in Rio de Janeiro, Brazil, from 26 to 31 July 2026 under the theme “Rethink. Rebuild. Rise.”

On 29 July 2026, the KAVI Institute of Clinical Research (KAVI-ICR) at the University of Nairobi hosted a ThermoFisher Innovation Day, welcoming a delegation from Scientific Laboratory Supplies (SLS) and Thermo Fisher Scientific together with scientists from Partners for Health and Development in Africa (PHDA) and the University of Nairobi's Faculty of Health Sciences.

Clinical and laboratory teams from Mbagathi County Hospital and Loitokitok Sub-County Hospital completed a week of intensive training before the dry run on 10 July 2026.

The Kenyan arm of the ZAFI study reached an important milestone this month with a five-day site initiation and training programme at KAVI-ICR in Nairobi.